RANI News and Press, Rani Therapeutics Holdings Inc. From 10/23/25

SAN JOSE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the appointment of Abraham...

Financing led by Samsara BioCapital, L.P. (“Samsara”) with participation from additional investors, including RA Capital Management, Anomaly, Special Situations Funds, Invus and Mr. Mir Imran Each of Samsara and Anomaly has the right to designate one member of the Compan...

A look at the top 10 most actives in the United States Beyond Meat Inc. (BYND) rose 146.3% to $3.62 on volume of 1,810,536,520 shares Yueda Digital Holding (YDKG) rose 28.0% to $0.0567 on volume of 807,880,810 shares AiRWA Inc. (YYAI) fell 19.2% to $0.0809 on volume of 632,991,260 shares ...

2025-10-21 13:15:09 ET DENVER, Colo., Oct 21, 2025 ( 247marketnews.com )- Wall Street’s midday tone is risk-on, with biotech, food tech, and sustainable materials stocks seeing outsized moves. iBio (NASDAQ:IBIO) is catching investor attention after announcing dual upcomin...

A look at the top 10 most actives in the United States Beyond Meat Inc. (BYND) rose 127.7% to $1.47 on volume of 1,117,806,955 shares AiRWA Inc. (YYAI) fell 17.3% to $0.1001 on volume of 366,562,519 shares Adaptimmune Therapeutics plc (ADAP) fell 70.5% to $0.059 on volume of 318,840,954 sha...

2025-10-20 15:00:56 ET Rani Therapeutics (NASDAQ: RANI) revealed a licensing agreement with Chugai Pharmaceutical (a 60% subsidiary of Roche [RHBBY]) for its RaniPill technology. The deal was accompanied by a $60 million private placement from leading healthcare institutions. The news s...

2025-10-20 14:20:15 ET Rani Therapeutics Overview I'm initiating coverage on Rani Therapeutics Holdings, Inc. ( RANI ) and believe that I should set it at a Buy rating. The reason why I believe that I should do this is because of three major pipeline advancements that could ...

2025-10-20 13:20:39 ET DENVER, Colo., Oct 20, 2025 ( 247marketnews.com )- Wall Street is buzzing this Friday as a mix of innovative biotech breakthroughs, next-gen partnerships, and surprising revenue beats drive a midday rally across select sectors. Here’s your editorial roundup...

A look at the top 10 most actives in the United States Beyond Meat Inc. (BYND) rose 46.2% to $0.9441 on volume of 248,997,232 shares Adaptimmune Therapeutics plc (ADAP) fell 70.1% to $0.0598 on volume of 138,511,757 shares Replimune Group Inc. (REPL) rose 101.3% to $9.06 on volume of 63,729...

2025-10-20 05:32:24 ET More on related stocks: Plug Power's Black Cloud Addressed (Rating Downgrade) Plug Power: Sell On Unwarranted AI Data Center Hype Plug Power: Don't Ignore Operational Issues Rani Therapeutics surges on Chugai licensing deal, private pla...